Use of C1 Inhibitor Subcutaneously in the United Kingdom: Insights from a National Real-World Retrospective Study
Ky-Lyn Tan, Moira Thomas, Anthony D Dorr, Lorena Lorenzo, Michael Tarzi, Malini Bhole, Efrem Eren, Xi Ying Soo, Sadia Noorani, Emily Zinser, Patrick F K Yo
Authors
- Anthony D. Dorr
- Emily Zinser
- Patrick Yong (ORCID: https://orcid.org/0000-0003-1736-2756)
- K C Tan (ORCID: https://orcid.org/0000-0002-4716-5692)
- Efrem Eren (ORCID: https://orcid.org/0000-0002-7815-6094)
- Sadia Noorani
- Xi Ying Soo (ORCID: https://orcid.org/0009-0008-2383-1516)
- Lorena Lorenzo
- Moira Thomas
- Malini Bhole
- Michael Tarzi
Institutions
- Barts Health NHS Trust (GB)
- Sandwell & West Birmingham Hospitals NHS Trust (GB)
- Southampton Hospital (US)
- Royal Sussex County Hospital (GB)
- Frimley Park Hospital (GB)
- Southampton General Hospital (GB)
- Dudley Group NHS Foundation Trust (GB)
- University of Surrey (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Royal Surrey NHS Foundation Trust (GB)
- Queen Elizabeth University Hospital (GB)
Publication Details
- Journal
- Clinical & Experimental Immunology
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1093/cei/uxag055
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00